Drug recall
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto…
FDA recall event 87648 · Class II · Apotex Corp.
Key facts
| Event ID | 87648 |
|---|---|
| Recall numbers | D-0324-2021 |
| Recalling firm | Apotex Corp. |
| Product type | Drugs |
| Products | Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate |
| Initiation date | Mar 31, 2021 |
| Report date | Apr 14, 2021 |
| City | Weston |
| State | FL |
| Country | United States |
| FEI number | 3006727872 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: